Follow-up study for a heart device in heart failure patients
Part of Heart & circulation clinical trials.
This study follows people with chronic heart failure to see how well an implanted device (called the Occlutech AFR) works and whether it is safe over time. It may help doctors better understand who benefits and how to manage treatment safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign written informed consent, and you are 18 or older
- You have ongoing heart failure symptoms that are at least moderate (NYHA class 2 or higher)
- You have higher pressure on the left side of the heart than the right side (a pressure difference of at least 5 mmHg on testing)
- Your heart pumping strength is low enough to fit the study (LVEF at least 15%); if your pumping is fairly preserved, specific blood marker levels must be elevated
- Your heart failure medicines have been stable for at least 1 month before joining
- You do NOT have several serious conditions (like very advanced heart failure, major right-heart failure, certain valve disease, recent serious clots/bleeding, or major lung disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a heart pacing approach in people with heart failure symptoms despite preserved heart pumping. It aims to see whether changing heart timing can improve how you feel and how your heart works during exercise.
This study tests a new type of heart failure device implant designed for patients with a specific heart rhythm problem called left bundle branch block. The device may help your heart pump better and reduce symptoms.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study compares two different ablation procedures (treatments that target heart rhythm triggers) for people with atrial fibrillation and reduced heart pumping. It aims to see which approach works best and is safest for improving your heart rhythm when you also have heart failure.
This trial tests a device that treats and monitors heart failure. It may help people with chronic heart failure and reduced heart function who still have symptoms despite standard treatments.
This trial tests a wirelessly implanted device that measures pressure in the left upper heart chamber (left atrial pressure) in people with advanced heart failure. By tracking that pressure, researchers hope to better understand disease status and guide care.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.